Neel Hammond

553 total citations
11 papers, 422 citations indexed

About

Neel Hammond is a scholar working on Pathology and Forensic Medicine, Oncology and Surgery. According to data from OpenAlex, Neel Hammond has authored 11 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 5 papers in Oncology and 3 papers in Surgery. Recurrent topics in Neel Hammond's work include Intraperitoneal and Appendiceal Malignancies (2 papers), Breast Cancer Treatment Studies (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). Neel Hammond is often cited by papers focused on Intraperitoneal and Appendiceal Malignancies (2 papers), Breast Cancer Treatment Studies (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). Neel Hammond collaborates with scholars based in United States, Australia and India. Neel Hammond's co-authors include Stephen E. Jones, Eugene M. McKelvey, James J. Butler, Terence S. Herman, Gerald E. Byrne, Danika L. Lew, Daniel P. Petrylak, E. David Crawford, Bruce G. Redman and Eric J. Small and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and European Respiratory Journal.

In The Last Decade

Neel Hammond

10 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Neel Hammond United States 7 156 146 146 126 106 11 422
JJ Spinelli Canada 8 144 0.9× 158 1.1× 72 0.5× 83 0.7× 184 1.7× 12 543
JM Zucker France 6 155 1.0× 67 0.5× 70 0.5× 73 0.6× 84 0.8× 10 310
Linda Hershon Canada 12 146 0.9× 40 0.3× 106 0.7× 166 1.3× 127 1.2× 15 437
Shigeo Nakamura Japan 9 71 0.5× 249 1.7× 88 0.6× 104 0.8× 215 2.0× 12 437
Subhash C. Gulati United States 7 89 0.6× 155 1.1× 114 0.8× 99 0.8× 134 1.3× 12 380
Antonella Montanini Italy 9 101 0.6× 354 2.4× 136 0.9× 34 0.3× 194 1.8× 14 430
B.G. Taal Netherlands 12 134 0.9× 152 1.0× 138 0.9× 164 1.3× 216 2.0× 21 538
Marin Nola Croatia 11 40 0.3× 129 0.9× 89 0.6× 66 0.5× 120 1.1× 31 405
Angelo Lattuada Italy 10 90 0.6× 235 1.6× 135 0.9× 115 0.9× 144 1.4× 15 391
D E Austin United Kingdom 9 99 0.6× 201 1.4× 68 0.5× 105 0.8× 109 1.0× 12 405

Countries citing papers authored by Neel Hammond

Since Specialization
Citations

This map shows the geographic impact of Neel Hammond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neel Hammond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neel Hammond more than expected).

Fields of papers citing papers by Neel Hammond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neel Hammond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neel Hammond. The network helps show where Neel Hammond may publish in the future.

Co-authorship network of co-authors of Neel Hammond

This figure shows the co-authorship network connecting the top 25 collaborators of Neel Hammond. A scholar is included among the top collaborators of Neel Hammond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neel Hammond. Neel Hammond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Musk, Arthur W., Nola Olsen, H. Alfonso, et al.. (2011). Predicting survival in malignant mesothelioma. European Respiratory Journal. 38(6). 1420–1424. 85 indexed citations
3.
Whitehead, Robert P., Joseph M. Unger, Lawrence E. Flaherty, et al.. (2002). A Phase II Trial of Pyrazine Diazohydroxide in Patients with Disseminated Malignant Melanoma and no Prior Chemotherapy – Southwest Oncology Group Study. Investigational New Drugs. 20(1). 105–111. 4 indexed citations
4.
Schroder, Louis E., Danika L. Lew, Robert C. Flanigan, et al.. (2001). Phase II evaluation of suramin in advanced renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 6(4). 145–148. 2 indexed citations
5.
Small, Eric J., Danika L. Lew, Bruce G. Redman, et al.. (2000). Southwest Oncology Group Study of Paclitaxel and Carboplatin for Advanced Transitional-Cell Carcinoma: The Importance of Survival as a Clinical Trial End Point. Journal of Clinical Oncology. 18(13). 2537–2544. 83 indexed citations
6.
Markman, Maurie, Howard D. Homesley, Julian C. Schink, et al.. (1996). Phase 1 Trial of Intraperitoneal AD-32 in Gynecologic Malignancies. Gynecologic Oncology. 61(1). 90–93. 4 indexed citations
7.
Livingston, Robert B., Susan Schulman, Brian R. Griffin, et al.. (1987). Combination chemotherapy and systemic irradiation consolidation for poor prognosis breast cancer. Cancer. 59(7). 1249–1254. 23 indexed citations
8.
Ahmann, Frederick R., Stephen E. Jones, Thomas E. Moon, et al.. (1985). Chemohormonal therapy for advanced breast cancer with tamoxifen, adriamycin, and cyclophosphamide (TAC). Cancer. 56(4). 730–737. 6 indexed citations
9.
Alberts, David S., et al.. (1985). Phase I trial of carboplatin-cyclophosphamide and iproplatin-cyclophosphamide in advanced ovarian cancer: a Southwest Oncology Group study. Cancer Treatment Reviews. 12. 83–92. 13 indexed citations
10.
Herman, Terence S., Neel Hammond, Stephen E. Jones, et al.. (1979). Involvement of the central nervous system by non-Hodgkin's lymphoma.The southwest oncology group experience. Cancer. 43(1). 390–397. 185 indexed citations
11.
Hammond, Neel, Stephen E. Jones, Sydney E. Salmon, Dennis D. Patton, & James M. Woolfenden. (1978). Predictive value of bone scans in an adjuvant breast cancer program. Cancer. 41(1). 138–142. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026